Clinical Trials List
2006-02-01 - 2007-04-30
Phase II
Terminated7
ICD-10C16.9
Malignant neoplasm of stomach, unspecified
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.9
Malignant neoplasm of stomach, unspecified
-
Trial Applicant
TTY Biopharm Company Limited
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 陳博明 Division of Hematology & Oncology
- Tzeon-jye Chiou Division of Hematology & Oncology
- Jacqueline Whang-Peng Division of Hematology & Oncology
- Yee Chao Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
- Chung-Pin Li Digestive System Department
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Ann-Lii Cheng Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Tsu-Yi Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
33 participants
-
Global
33 participants
